Appendix A
Workshop on Methods of Producing Monoclonal Antibodies
November 10, 1998
Agenda
9:00–9:30 Is the mouse ascites method painful?-Via Telephone Gebhart
9:30–3:00 Presentation by workshop participants:
9:30 - Mr. Tim DeSutter
9:45 - Dr. James Valdes
10:00 - Dr. John Reddington
10:15 - Break
10:30 - Dr. Simon Saxby
10:45 - Dr. Vahe Bedian
11:00 - Dr. Joseph Chandler
11:15 - Ms. Tracie Letterman
11:30 - Dr. Paul E. Thomas
11:45 - Questions and Answers
12:00 - Lunch for Committee and Workshop Participants
1:00 - Dr. Kathryn Stein
1:15 - Dr. Peter Maxim
1:30 - Dr. Dennis Dixon
1:45 - Dr. Arturo Casadevall
2:00 - Dr. John McArdle
2:15 - Dr. Louis Detolla
3:00 Adjourn
Workshop Participants
1. |
Dr.Vahe Bedian, Principal Research Investigator, Pfizer Central Research |
2. |
Dr. Arturo Casadevall, Department of Microbiology & Immunology, Albert Einstein College of Medicine |
3. |
Dr. Joseph Chandler, President, Maine Biotechnology Services, Inc. |
4. |
Mr. Tim DeSutter, Vice President, Integra Biosciences, Inc. |
5. |
Dr. Louis Detolla, Chairman, Comparative Medicine Program, University of Maryland |
6. |
Dr. Dennis Dixon, Chief, Bacteriology and Mycology Branch, Division of Microbiology and Infectious Diseases, NIH/NIAID |
7. |
Ms. Tracie Letterman, Esquire, International Center for Technology Assessment |
8. |
Dr. Peter Maxim, FDA/CDRH |
9. |
Dr. John McArdle, Director, Alternatives Research and Development Foundation |
10. |
Dr. John Reddington, DiagXotics, Inc. |
11. |
Dr. Simon Saxby, Director, Contract Operations, Unisyn Technologies |
12. |
Dr. Kathryn Stein, Director, Division of Monoclonal Antibodies, FDA/CBER |
13. |
Dr. Paul E. Thomas, Professor, Department of Chemical Biology, Rutgers the State University |
14. |
Dr. James Valdes, Edgewood Research Development & Engineering Center |